Ipamorelin is a selective growth hormone secretagogue that triggers GH release through a different (ghrelin-receptor) pathway
Visible Results Users have reported seeing significant improvements in their skin tone, texture, and overall health within weeks of use
Q.YanD.et al (2019)
Start your intake Standard GHK-Cu Dosage Ranges in Clinical Practice Most GHK-Cu protocols in research and clinical settings start at 0.51 mg weekly or 23 mg monthly via subcutaneous injection
However, if you have a low B12 level or a vitamin B12 deficiency, it can cause physical, neurological, and psychological problems
Human safety data is limited, and risks may depend on dose, route, sourcing, health history, and other medications